Surgery did not significantly alter percentages of CD133+ CTCs in the surgery only (grey dots), aRT (middle orange dots) or aCRT (middle blue dots) cohorts in patients with vulvar or cervical cancer (Fig. 3A, B). This evidence concerns the gene PROM1 and cervical carcinoma.